CAM
PAHC icon

Cresset Asset Management’s Phibro Animal Health PAHC Stock Holding History

Cresset Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14
Closed – – 1319
2019
Q1 		$0 Buy
14
+3
+27% +$93 ﹤0.01% 2074
2018
Q4 		$0 Buy
+11
New +$415 ﹤0.01% 1738

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cresset Asset Management's PAHC Position: Q2 2019 in Review

Cresset Asset Management sold out of Phibro Animal Health (PAHC) in Q2 2019, closing a stake of 14 shares.

Cresset Asset Management first reported a position in PAHC in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 168 funds tracked by Wall St. Rank hold PAHC as of Q2 2019.

  • Cresset Asset Management reported no remaining Phibro Animal Health position as of Q2 2019 after selling out during the quarter.
  • Cresset Asset Management sold 14 Phibro Animal Health shares in Q2 2019.
  • Cresset Asset Management first reported a position in Phibro Animal Health in Q4 2018 and held it in 2 quarters.
  • Cresset Asset Management's Phibro Animal Health position peaked at $0 in Q1 2019.
  • 168 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2019.

Based on Cresset Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.